A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 12, Issue 6, 2012, Pages 393-399

  Rose, Adam C ^a   Shenoy, Pareen J ^a   Garrett, Gia ^a   Seward, Miray ^a   Kucuk, Roy A ^a   Doksansky, Hannah ^a   Nastoupil, Loretta J ^a   Flowers, Christopher R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Follicular lymphoma; Ibritumomab tiuxetan; Iodine 131 tositumomab; Meta analysis; Radioimmunotherapy; Review

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; IBRITUMOMAB TIUXETAN; PREDNISONE; RITUXIMAB; TOSITUMOMAB I 131; VINCRISTINE;

CANCER REGRESSION; CANCER SURVIVAL; CONSOLIDATION CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; FOLLICULAR LYMPHOMA; HUMAN; META ANALYSIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIOIMMUNOTHERAPY; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, FOLLICULAR; RADIOIMMUNOTHERAPY; YTTRIUM RADIOISOTOPES;

EID: 84869450523     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.09.012     Document Type: Review

References (26)

1. L.M. Morton, S.S. Wang, S.S. Devesa Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma The Non-Hodgkin's Lymphoma Classification Project Blood 89 1997 3909 3918
3. G.A. Salles Clinical features, prognosis and treatment of follicular lymphoma Ash Educ Programs Book 1 2007 216 225
4. A. Freedman Follicular lymphoma: 2011 update on diagnosis and management Am J Hematol 86 2011 768 775
5. D. Tan, S.J. Horning Follicular lymphoma: clinical features and treatment Hematol Oncol Clin North Am 22 2008 863 882
6. J.W. Friedberg, M.D. Taylor, J.R. Cerhan Follicular lymphoma in the United States: first report of the National LymphoCare study J Clin Oncol 27 2009 1202 1208
7. W. Hiddemann, M. Kneba, M. Dreyling Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group Blood 106 2005 3725 3732
8. G. Salles, J.F. Seymour, F. Offner Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Lancet 377 2011 42 51
9. T. Illidge, F. Morschhauser Radioimmunotherapy in follicular lymphoma Best Pract Res Clin Haematol 24 2011 279 293
10. M.S. Kaminski, M. Tuck, J. Estes 131I-tositumomab therapy as initial treatment for follicular lymphoma N Engl J Med 352 2005 441 449
11. M.S. Kaminski, K.R. Zasadny, I.R. Francis Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody N Engl J Med 329 1993 459 465
12. F. Morschhauser, J. Radford, A. Van Hoof Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma J Clin Oncol 26 2008 5156 5164
13. O.W. Press, J.M. Unger, L.M. Rimsza A phase III randomized intergroup trial (SWOG S0016) of CHOP chemotherapy plus rituximab vs. CHOP chemotherapy plus iodine-131-tositumomab for the treatment of newly diagnosed follicular non-Hodgkin's lymphoma ASH Annual Meeting Abstracts 118 2011 98
14. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
15. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 110 129
16. J.P. Higgins, S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
17. C.B. Begg, M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. M. Egger, G. Davey Smith, M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
19. S. Duval, R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
20. J.D. Hainsworth, D.R. Spigel, T.M. Markus Rituximab plus short-duration chemotherapy followed by yttrium-90 ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium Clin Lymphoma Myeloma 9 2009 223 228
21. S.A. Jacobs, S.H. Swerdlow, J. Kant Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma Clin Cancer Res 14 2008 7088 7094
22. J.P. Leonard, M. Coleman, L. Kostakoglu Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma J Clin Oncol 23 2005 5696 5704
23. B.K. Link, P. Martin, M.S. Kaminski Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study J Clin Oncol 28 2010 3035 3041
24. O.W. Press, J.M. Unger, R.M. Braziel Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911 J Clin Oncol 24 2006 4143 4149
25. P.L. Zinzani, M. Tani, A. Pulsoni Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ) Lancet Oncol 9 2008 352 358
26. K. Dwan, D.G. Altman, J.A. Arnaiz Systematic review of the empirical evidence of study publication bias and outcome reporting bias PLoS ONE 3 2008 e3081